Cathepsins: Key modulators of cell death and inflammatory responses

Biochemical Pharmacology

Volumn 76, Issue 11, 2008, Pages 1374-1382

  Conus, Sébastien ^a   Simon, Hans Uwe ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Apoptosis; Caspase; Cathepsin; Immune system; Inflammation; Reactive oxygen species

Indexed keywords

CATHEPSIN;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL DEATH; HOMEOSTASIS; HUMAN; INFLAMMATION; INNATE IMMUNITY; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; CATHEPSINS; CELL DEATH; HUMANS; IMMUNE SYSTEM; INFLAMMATION; MICE;

EID: 55949117482     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2008.07.041     Document Type: Review

References (98)

1. Weiss S.J. Mechanisms of disease: tissue destruction by neutrophils. N Engl J Med 320 (1989) 365-376
2. Savill J., and Fadok V. Corpse clearance defines the meaning of cell death. Nature 407 (2000) 770-776
3. Simon H.U. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev 193 (2003) 101-110
4. Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., and Peter M.E. Apoptosis signalling by death receptors. Eur J Biochem 254 (1998) 439-459
5. Simon H.U. Regulation of eosinophil and neutrophil apoptosis-similarities and differences. Immunol Rev 179 (2001) 156-162
6. Lamkanfi M., Festjens N., Declerq W., Vanden Berghe T., and Vandenabeele P. Caspases in cell survival, proliferation and differentiation. Cell Death Differ 14 (2007) 44-55
7. Salvesen G.S. A lysosomal protease enters the death scene. J Clin Invest 107 (2001) 21-22
8. Lockshin R.A., and Zakeri Z. Caspase-independent cell death?. Oncogene 23 (2004) 2766-2773
9. Foghsgaard L., Wissing D., Mauch D., Lademann U., Bastholm L., Boes M., et al. Cathepsin B acts as a dominant execution protease in tumor cell apoptosis induced by tumor necrosis factor. J Cell Biol 153 (2001) 999-1009
10. Guicciardi M.E., Miyoshi H., Bronk S.F., and Gores G.J. Cathepsin B knockout mice are resistant to tumor necrosis factor-alpha-mediated hepatocyte apoptosis and liver injury: implications for therapeutic applications. Am J Pathol 159 (2001) 2045-2054
11. Roberg K., Kågedal K., and Öllinger K. Microinjection of cathepsin D induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 161 (2002) 89-96
12. Chwieralski C.E., Welte T., and Bühling F. Cathepsin-regulated apoptosis. Apoptosis 11 (2006) 143-149
13. Ishidoh K., and Kominami E. Processing and activation of lysosomal proteinases. Biol Chem 383 (2002) 1827-1831
14. Turk B., Turk D., and Turk V. Lysosomal cysteine proteases: more than scavengers. Biochem Biophys Acta 1477 (2000) 98-111
15. Vasiljeva O., and Turk B. Dual contrasting roles of cysteine cathepsins in cancer progression: apoptosis versus tumour invasion. Biochimie 90 (2008) 380-386
16. Turk B., Bieth J.G., Bjork I., Dolenc I., Turk D., Cimerman N., et al. Regulation of the activity of lysosomal cystein proteinases by pH-induced inactivation and/or endogenous protein inhibitors, cystatins. Biol Chem Hoppe Seyler 376 (1995) 225-230
17. Turk B., and Stoka V. Protease signalling in cell death: caspases versus cysteine cathepsins. FEBS Lett 581 (2007) 2761-2767
18. Gottlieb R.A., Nordberg J., Skowronski E., and Babior B.M. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 93 (1996) 654-658
19. Matsuyama S., Llopis J., Deveraux Q.L., Tsien R.Y., and Reed J.C. Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2 (2000) 318-325
20. Vasiljeva O., Reinheckel T., Peters C., Turk D., Turk V., and Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr Pharm Des 13 (2007) 385-401
21. Guicciardi M.E., Deussing J., Miyoshi H., Bronk S.F., Svingen P.A., Peters C., et al. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106 (2000) 1127-1137
22. Stoka V., Turk B., Schendel S.L., Kim T.H., Cirman T., Snipas S.J., et al. Lysosomal protease pathways to apoptosis. Cleavage of Bid, not pro-caspases, is the most likely route. J Biol Chem 276 (2001) 3149-3157
23. Li W., Yuan X., Nordgren G., Dalen H., Dubowchik G.M., Firestone R.A., et al. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 470 (2000) 35-39
24. Boya P., Andreau K., Poncet D., Zamzami N., Perfettini J.L., Metivier D., et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 197 (2003) 1323-1334
25. Bursch W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ 8 (2001) 569-581
26. Guicciardi M.E., Leist M., and Gores G.J. Lysosomes in cell death. Oncogene 23 (2004) 2881-2890
27. Cirman T., Oresic K., Mazovec G.D., Turk V., Reed J.C., Myers R.M., et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279 (2004) 3578-3587
28. Kagedal K., Zhao M., Svensson I., and Brunk U.T. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359 (2001) 335-343
29. Li W., Yuan X.M., Ivanova S., Tracey K.J., Eaton J.W., and Brunk U.T. 3-Aminopropanal, formed during cerebral ischaemia, is a potent lysosomotropic neurotoxin. Biochem J 371 (2003) 429-436
30. Boya P., Gonzalez-Polo R.A., Poncet D., Andreau K., Vieira H.L., Roumier T., et al. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22 (2003) 3927-3936
31. Bröker L.E., Huisman C., Span S.W., Rodriguez J.A., Kruyt F.A., and Giaccone G. Cathepsin B mediates caspase-independent cell death induced by microtubule stabilizing agents in non-small cell lung cancer cells. Cancer Res 64 (2004) 27-30
32. Hishita T., Tada-Oikawa S., Tohyama K., Miura Y., Nishihara T., Tohyama Y., et al. Caspase-3 activation by lysosomal enzymes in cytochrome c-independent apoptosis in myelodysplastic syndrome-derived cell line P39. Cancer Res 61 (2001) 2878-2884
33. Johansson A.C., Steen H., Ollinger K., and Roberg K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ 10 (2003) 1253-1259
34. Bidere N., Lorenzo H.K., Carmona S., Laforge M., Harper F., Dumont C., et al. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278 (2003) 31401-31411
35. Roberts L.R., Adjei P.N., and Gores G.J. Cathepsins as effector proteases in hepatocyte apoptosis. Cell Biochem Biophys 30 (1999) 71-88
36. Ostenfeld M.S., Fehrenbacher N., Hoyer-Hansen M., Thomsen C., Farkas T., and Jäättelä M. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res 65 (2005) 8975-8983
37. Erdal H., Berndtsson M., Castro J., Brunk U., Shoshan M.C., and Linder S. Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 102 (2005) 192-197
38. Mijatovic T., Mathieu V., Gaussin J.F., De Neve N., Ribeaucour F., Van Quaquebeke E., et al. Cardenolide-induced lysosomal membrane permeabilization demonstrates therapeutic benefits in experimental human non-small cell lung cancers. Neoplasia 8 (2006) 402-412
39. Barbosa C.M., Oliveira C.R., Nascimento F.D., Smith M.C., Fausto D.M., Soufen M.A., et al. Biphosphonic palladacycle complex mediates lysosomal-membrane permeabilization and cell death in K562 leukaemia cells. Eur J Pharmacol 542 (2006) 37-47
40. Roberts L.R., Kurosawa H., Bronk S.F., Fesmier P.J., Agellon L.B., Leung W.Y., et al. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes. Gastroenterol 113 (1997) 1714-1726
41. Deiss L.P., Galinka H., Berissi H., Cohen O., and Kimchi A. Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 15 (1996) 3861-3870
42. Wu G.S., Saftig P., Peters C., and El-Deiry W.S. Potential role for cathepsin D in p53-dependent tumor suppression and chemosensitivity. Oncogene 16 (1998) 2177-2183
43. Tobin D.J., Foitzik K., Reinheckel T., Mecklenburg L., Botchkarev V.A., Peters C., et al. The lysosomal protease cathepsin L is an important regulator of keratinocyte and melanocyte differentiation during hair follicle morphogenesis and cycling. Am J Pathol 160 (2002) 1807-1821
44. Stoka V., Turk V., and Turk B. Lysosomal cysteine cathepsins: signalling pathways in apoptosis. Biol Chem 388 (2007) 555-560
45. Roberg K., and Ollinger K. Oxidative stress causes relocation of the lysosomal enzyme cathepsin D with ensuing apoptosis in neonatal rat cardiomyocytes. Am J Pathol 152 (1998) 1151-1156
46. 2-mediated damage to lysosomal membranes of J-774 cells. Free Radic Res Commun 18 (1993) 71-85
47. Persson H.L., Kurz T., Eaton J.W., and Brunk U.T. Radiation-induced cell death: importance of lysosomal destabilization. Biochem J 389 (2005) 877-884
48. Yeung B.H., Huang D.C., and Sinicrope F.A. PS-341 (bortezomib) induces lysosomal cathepsin B release and a caspase-2-dependent mitochondrial permeabilization and apoptosis in human pancreatic cancer cells. J Biol Chem 281 (2006) 11923-11932
49. Reiners Jr. J.J., Caruso J.A., Mathieu P., Chelladurai B., Yin X.M., and Kessel D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ 9 (2002) 934-944
50. Caruso J.A., Mathieu P.A., Joiakim A., Leeson B., Kessel D., Sloane B.F., et al. Differential susceptibilities of murine hepatoma 1c1c7 and Tao cells to the lysosomal photosensitizer NPe6: influence of aryl hydrocarbon receptor on lysosomal fragility and protease contents. Mol Pharmacol 65 (2004) 1016-1028
51. Ichinose S., Usuda J., Hirata T., Inoue T., Ohtani K., Maehara S., et al. Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Int J Oncol 29 (2006) 349-355
52. Gyrd-Hansen M., Farkas T., Fehrenbacher N., Bastholm L., Hoyer-Hansen M., Elling F., et al. Apoptosome-independent activation of the lysosomal cell death pathway by caspase-9. Mol Cell Biol 26 (2006) 7880-7891
53. Werneburg N., Guicciardi M.E., Yin X.M., and Gores G.J. TNF-α-mediated lysosomal permeabilization is FAN- and caspase-8/Bid-dependent. Am J Physiol Gastrointest Liver Physiol 287 (2004) G436-G443
54. Guicciardi M.E., Bronk S.F., Werneburg N., Yin X.M., and Gores G.J. Bid is upstream of lysosome-mediated caspase 2 activation in tumor necrosis factor α-induced hepatocyte apoptosis. Gastroenterologia 129 (2005) 269-284
55. Nagaraj N.S., Vigneswaran N., and Zacharias W. Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells. J Cancer Res Clin Oncol 132 (2006) 171-183
56. Chen W., Li N., Chen T., Han Y., Li C., Wang Y., et al. The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway. J Biol Chem 280 (2005) 40985-40995
57. Kagedal K., Johansson A.C., Johansson U., Heimlich G., Roberg K., Wang N.S., et al. Lysosomal membrane permeabilization during apoptosis-involvement of Bax?. Int J Exp Pathol 86 (2005) 309-321
58. Feldstein A.E., Werneburg N.W., Li Z., Bronk S.F., and Gores G.J. Bax inhibition protects against free fatty acid-induced lysosomal permeabilization. Am J Physiol Gastrointest Liver Physiol 290 (2006) G1339-G1346
59. Zhao M., Eaton J.W., and Brunk U.T. Protection against oxidant-mediated lysosomal rupture: a new anti-apoptotic activity of Bcl-2?. FEBS Lett 485 (2000) 104-108
60. Zhao M., Eaton J.W., and Brunk U.T. Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett 509 (2001) 405-412
61. Nylandsted J., Gyrd-Hansen M., Danielewicz A., Fehrenbacher N., Lademann U., Hoyer-Hansen M., et al. Heat shock protein 70 promotes cell survival by inhibiting lysosomal membrane permeabilization. J Exp Med 200 (2004) 425-435
62. Conus S., Perozzo R., Reinheckel T., Peters C., Scapozza L., Yousefi S., et al. Caspase-8 is activated by cathepsin D initiating neutrophil apoptosis during the resolution of inflammation. J Exp Med 205 (2008) 685-698
63. Roberg K., Johansson U., and Ollinger K. Lysosomal release of cathepsin D precedes relocation of cytochrome c and loss of mitochondrial transmembrane potential during apoptosis induced by oxidative stress. Free Radic Biol Med 27 (1999) 1228-1237
64. Blomgran R., Zheng L., and Stendahl O. Cathepsin-cleaved Bid promotes apoptosis in human neutrophils via oxidative stress-induced lysosomal membrane permeabilization. J Leukoc Biol 81 (2007) 1213-1223
65. Heinrich M., Neumeyer J., Jakob M., Hallas C., Tchikov V., Winoto-Morbach S., et al. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 11 (2004) 550-563
66. Saelens X., Festjens N., Vande Walle L., van Gurp M., van Loo G., and Vandenabeele P. Toxic proteins released from mitochondria in cell death. Oncogene 23 (2004) 2861-2874
67. Zhao M., Antunes F., Eaton J.W., and Brunk U.T. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 270 (2003) 3778-3786
68. Houseweart M.K., Vilaythong A., Yin X.M., Turk B., Noebels J.L., and Myers R.M. Apoptosis caused by cathepsins does not require Bid signalling in an in vivo model of progressive myoclonus epilepsy (EPM1). Cell Death Differ 10 (2003) 1329-1335
69. Droga-Mazovec G., Bojic L., Petelin A., Ivanova S., Romih R., Repnik U., et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of Bid and anti-apoptotic Bcl-2 homologues. J Biol Chem 283 (2008) 19140-19150
70. Gocheva V., Zeng W., Ke D., Klimstra T., Reinheckel T., Peters C., et al. Distinct roles for cysteine cathepsins genes in multistage tumorigenesis. Genes Dev 20 (2006) 543-556
71. Schmeiser K., and Grand R.J. The fate of E- and P-cadherin during the early stages of apoptosis. Cell Death Differ 6 (1999) 377-386
72. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5 (2004) 443-453
73. Schotte P., Van Criekinge W., Van de Craen M., Van Loo G., Desmedt M., Grooten J., et al. Cathepsin B-mediated activation of the pro-inflammatory caspase-11. Biochem Biophys Res Commun 251 (1998) 379-387
74. Vancompernolle K., Van Herreweghe F., Pynaert G., Van de Craen M., De Vos K., Totty N., et al. Atractyloside-induced release of cathepsin B, a protease with caspase-processing activity. FEBS Lett 438 (1998) 150-158
75. Martinon F., Burns K., and Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of pro-IL-beta. Mol Cell 10 (2002) 417-426
76. Ishisaka R., Utsumi T., Kanno T., Arita K., Katunuma N., Akiyama J., et al. Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct 24 (1999) 465-470
77. Ishisaka R., Kanno T., Akiyama J., Yoshioka T., Utsumi K., and Utsumi T. Activation of caspase-3 by lysosomal cysteine proteases and its role in 2,2′-azobis-(2-amidinopropane)dihydrochloride (AAPH)-induced apoptosis in HL-60 cells. J Biochem 129 (2001) 35-41
78. Altznauer F., Conus S., Cavalli A., Folkers G., and Simon H.U. Calpain-1 regulates Bax and subsequent Smac-dependent caspase-3 activation in neutrophil apoptosis. J Biol Chem 279 (2004) 5947-5957
79. Yousefi S., Perozzo R., Schmid I., Ziemiecki A., Schaffner T., Scapozza L., et al. Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8 (2006) 1124-1132
80. Leist M., and Jäättelä M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mol Cell Biol 2 (2001) 589-598
81. Lockshin R.A., and Zackeri Z. Caspase-independent cell deaths. Curr Opin Cell Biol 14 (2002) 727-733
82. Bröker L.E., Kruyt F.A.E., and Giaccone G. Cell Death Independent of Caspases: A Review. Clin Cancer Res 11 (2005) 3155-3162
83. Jäättelä M., and Tschopp J. Caspase-independent cell death in T lymphocytes. Nat Immunol 4 (2003) 416-423
84. Li J.H., and Pober J.S. The cathepsin B death pathway contributes to TNF plus IFN-gamma-mediated human endothelial injury. J Immunol 175 (2005) 1858-1866
85. Yu S.W., Wang H., Poitras M.F., Coombs C., Bowers W.J., Federoff H.J., et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297 (2002) 259-263
86. Gobeil S., Boucher C.C., Nadeau D., and Poirier G.G. Characterization of the necrotic cleavage of poly(ADP-ribose) polymerase (PARP-1): implication of lysosomal proteases. Cell Death Differ 8 (2001) 588-594
87. Yamashima T., Kohda Y., Tsuchiya K., Ueno T., Yamashita J., Yoshioka T., et al. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur J Neurosci 10 (1998) 1723-1733
88. Reggiori F., and Klionsky D.J. Autophagy in the eukaryotic cell. Eukaryot Cell 1 (2002) 11-21
89. Michallet M.C., Saltel F., Preville X., Flacher M., Revillard J.P., and Genestier L. Cathepsin B-dependent apoptosis triggered by antithymocyte globulins: a novel mechanism of T-cell depletion. Blood 102 (2003) 3719-3726
90. Michallet M.C., Saltel F., Flacher M., Revillard J.P., and Genestier L. Cathepsin-dependent apoptosis triggered by supraoptimal activation of lymphocytes: a possible mechanism of high dose tolerance. J Immunol 172 (2004) 5405-5414
91. Kishimoto H., and Sprent J. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naïve murine CD4+ T cells. J Immunol 163 (1999) 1817-1826
92. Alexander-Miller M.A., Leggatt G.R., Sarin A., and Berzofsky J.A. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J Exp Med 184 (1996) 485-492
93. Chapman H.A. Endosomal proteases in antigen presentation. Curr Opin Immunol 18 (2006) 78-84
94. Zavasnik-Bergant T., and Turk B. Cysteine cathepsins: destruction ability versus immunomodulation capacity in immune cells. Biol Chem 388 (2007) 1141-1149
95. Fehrenbacher N., and Jäättelä M. Lysosomes as targets for cancer therapy. Cancer Res 65 (2005) 2993-2995
96. Farina F., Cappello F., Todaro M., Bucchieri F., Peri G., Zummo G., et al. Involvement of caspase-3 and GD3 ganglioside in ceramide-induced apoptosis in Farber's disease. J Histochem Cytochem 48 (2000) 57-62
97. Pennacchio L.A., Lehesjoki A.E., Stone N.E., Willour V.L., Virtaneva K., Miao J., et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271 (1996) 1731-1734
98. Pennacchio L.A., Bouley D.M., Higgins K.M., Scott M.P., Noebels J.L., and Myers R.M. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice. Nat Genet 20 (1998) 251-258